Table 2.
Disparities Analyses (FY 1995–2006): Percent Difference (Δ) in Spending or Likelihood of Use, Blacks or Latinos versus Whites, Stratified by SUD Comorbidity Status
| Psychotropic Drugs |
Total Mental Health |
Total Health |
||||
|---|---|---|---|---|---|---|
| Group by SUD Comorbidity Status | Δ | β | Δ | β | Δ | β |
| A. Psychotropic drugs, total mental health, and total health: levels of spending | ||||||
| Blacks | ||||||
| Without SUD | −67** | −1.114 | −24** | −0.276 | −19** | −0.206 |
| With SUD | −70** | −1.203 | −1** | −0.009 | −2** | −0.020 |
| Latinos | ||||||
| Without SUD | −26** | −0.303 | −26** | −0.301 | −13** | −0.140 |
| With SUD | −20** | −0.218 | −17** | −0.189 | −7** | −0.067 |
| Likelihood of Use |
Levels of Spending |
|||||
| Group by SUD Comorbidity Status | Δ | β | Δ | β | ||
| B. Inpatient psychiatric: likelihood of use and levels of spending among users | ||||||
| Blacks | ||||||
| Without SUD | −11* | −0.121 | −1 | −0.014† | ||
| With SUD | +18** | +0.168 | −1 | −0.014† | ||
| Latinos | ||||||
| Without SUD | −18** | −0.195† | +1 | +0.013† | ||
| With SUD | −18** | −0.195† | +1 | +0.013† | ||
p value .000.
p value <.01.
SUD comorbidity does not moderate race effect (Race*SUD interaction term is not significant).